Venture Funds 3D Enabled Biotech
May 25, 2012- Share:
Nexus Medical and Technology Capital has led a Series A funding for Kiyatec, with Upstate Carolina Angel Network also participating. The biotech company provides 3D cell culture technology used by the pharmaceutical, biomedical and life science industries for in vitro prediction of human biochemical responses.
- Share:
-
-
-
-